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Dialysis S123P < 0.05) infibrotic peritoneal tissues. The down-regulated expression level
of miRe200a was also validated by real-time PCR in larger cohorts
(P < 0.05). Then, the expression level of miRe200a was detected in the
EMT process of human peritoneal mesothelium cells. During the process of
TGFeb1 induced EMT, miRe200a was significantly downeregulated
compared with the control (P < 0.05).
Conclusion: Down-regulated expression of miR-200a was observed both dur-
ing peritoneal fibrosis and TGF-b1 induced EMT in vivo and in vitro, suggest-
ing that miR-200a may be involved in the peritoneum fibrosis by regulating
the target genes of EMT.
Fig. 1. A, B: peritoneal fibrosis in a mouse model of PD. C, D: peritoneal
fibrosis index expression. E, F: EMT index expression during the EMT process
of human peritoneal mesothelium cells. G: miR-200a expression level down-
regulated during the EMT process. NPT: normal peritoneal tissue, FPT:
fibrotic peritoneal tissue,* P < 0 05, )) P < 0.01.http://dx.doi.org/10.1016/j.hkjn.2015.09.189
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Association Between Compliance with Visiting Nephrologist and Clinical
Outcomes of Remote Peritoneal Dialysis Patients
Chunyan Yi, Qunying Guo, Jianxiong Lin, Xueqing Yu, Xiao Yang
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Objective: To investigate the association between compliancewith visiting the
nephrologists and clinical outcomes of remote PD patients in Southern China.
Methods: In this retrospective cohort study, incident remote (travel distance
50 km) PD patients in our PD center from January 2006 to December 2012were enrolled and followed up until December 2014. According to the time
intervals of visiting the attending nephrologists, the patients were divided
into regular visiting group (1e6 months) and irregular visiting group (>6
months). The clinical outcomes were compared between the two groups.
Results: A total of 966 incident remote PD patients whose mean age was
45.9 14.4 years were enrolled. 38.0% of these patients were female, and
19.3% of them were diabetic. The median duration on PD was 36.0
(20.8e51.5)months. Comparedwith irregular visiting group (nZ 154), patients
with regular visiting (nZ 812) had higher levels of hemoglobin, serum albumin,
serum calcium, and lower systolic blood pressure, serum phosphorus, serum
creatinine (all p< 0.05). Theperitonitis rate of patients in regular visiting group
was significantly lower than that in irregular visiting group (0.15 vs. 0.20 epi-
sodes per patient-year, p< 0.001). The technique survival rateswerenot signif-
icantly different between the two groups. At the end of 1, 3, and 5 years,
patient survival rates were 97.2%, 88.1% and 76.0% in regular visiting group,
and 89.9%, 71.1% and 52.4% in irregular visiting group (p < 0.001). Advanced
age [hazard ratio (HR), 1.05 (95% CI, 1.03e1.06); p < 0.001], diabetes mellitus
[HR, 2.15 (95% CI, 1.44e3.21); p< 0.001], lower hemoglobin [HR, 0.99 (95% CI,
0.98e0.99); pZ 0.01] and poor compliance for visiting the attending nephrol-
ogists regularly [HR, 2.49 (95% CI, 1.69e3.68); p < 0.001] were risk factors for
all-cause mortality after adjustment for travel distance, gender, high-sensi-
tivity C-reactive protein, urine output, serum albumin and uric acid.
Conclusion: Visiting the attending nephrologists regularly was associated
with better outcomes of the remote PD patients.http://dx.doi.org/10.1016/j.hkjn.2015.09.1900148
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Objective: To investigate the influence of fluid management guided by bio-
impedance analysis (BIA) on clinical outcomes in peritoneal dialysis (PD)
patients.
Methods: This was a prospective randomized controlled trial registered on
the clinical trials website (No: NCT02000128). The prevalent PD patients
with volume overload [extracellular water (ECW) / total body water (TBW)
 0.40] were recruited from 1st July 2013 to 30th March 2014, and were ran-
domized to BIA group (fluid management guided by BIA) and control group
(guided by doctors’ experience) to reduce their fluid overload for 1 year.
Results: A total of 240 eligible participants (mean age of 49.6 15.4, 50.8%
male) with a median vintage of 32 (17, 50) months were enrolled. At the end
of the study, 11 (4.58%) patients died, 21 (8.75%)were permanently transferred
to HD and 11 (4.58%) to kidney transplant. The 1-year mortality was not statis-
tically different between the two groups (BIA vs. control: 2.5 vs. 6.7 events per
100 patient$year, p Z 0.12), while the technique survival had a trend to be
higher in the BIA group (90.8% vs. 82.5%, p Z 0.06). Less hospitalization was
observed in the BIA group (1/51 patient$months vs 1/27 patient$months,
p Z 0.01), among which the incidence of non-catheter associated infections
(17 episodes vs. 4 episodes, pZ 0.007) and emergency cases due to hyperten-
sion (11.1% vs. 5%, pZ 0.07) were significantly lower in the BIA group. In addi-
tion, the decline rate of ECW/TBW was much faster in the BIA group than the
control (p Z 0.02). The left ventricular mass index (200.12 47.43 vs
253.88 71.59 g/m2, p＜ 0.001), the nutrition status and inflammation were
significantly improved in the BIA group compared with the control.
Conclusion: Volume management guided by BIA is an efficient way to alle-
viate fluid overload and improve cardiac dilation and remodeling, therefore
decreasing the hospitalization rate and improving technique survival.http://dx.doi.org/10.1016/j.hkjn.2015.09.191
